ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Vivos Therapeutics Inc

Vivos Therapeutics Inc (VVOS)

3,11
-0,08
(-2,51%)
Geschlossen 31 März 10:00PM
3,12
0,01
(0,32%)
Nach Börsenschluss: 12:42AM
Fortg. Diagramm
Rendering Error

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
3,12
Gebot
2,85
Fragen
3,36
Volumen
125.838
2,84 Tagesbereich 3,36
1,91 52-Wochen-Bereich 6,28
Marktkapitalisierung
Handelsende
3,19
Handelsbeginn
3,16
Letzter Handelszeitpunkt
Finanzvolumen
US$ 381.092
VWAP
3,0284
Durchschnittliches Volumen (3 Mio.)
188.206
Ausgegebene Aktien
4.835.300
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,11
Gewinn pro Aktie (EPS)
-2,81
Erlöse
13,8M
Nettogewinn
-13,58M

Über Vivos Therapeutics Inc

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral applian... Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Vivos Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker VVOS. The last closing price for Vivos Therapeutics was US$3,19. Over the last year, Vivos Therapeutics shares have traded in a share price range of US$ 1,91 to US$ 6,28.

Vivos Therapeutics currently has 4.835.300 shares in issue. The market capitalisation of Vivos Therapeutics is US$15,42 million. Vivos Therapeutics has a price to earnings ratio (PE ratio) of -1.11.

VVOS Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.4-11.36363636363.523.80923.07580243.42679044CS
4-0.39-11.11111111113.513.81173.07704413.42686403CS
12-1.08-25.71428571434.26.283.011882064.29636745CS
260.4516.85393258432.676.282.2251882133.91633457CS
52-1.58-33.61702127664.76.281.914652613.85743798CS
156-58.63-94.947368421161.75741.91103676416.62141532CS
260-173.63-98.2347949081176.75360.251.91110134851.90078727CS

VVOS - Frequently Asked Questions (FAQ)

What is the current Vivos Therapeutics share price?
The current share price of Vivos Therapeutics is US$ 3,12
How many Vivos Therapeutics shares are in issue?
Vivos Therapeutics has 4.835.300 shares in issue
What is the market cap of Vivos Therapeutics?
The market capitalisation of Vivos Therapeutics is USD 15,42M
What is the 1 year trading range for Vivos Therapeutics share price?
Vivos Therapeutics has traded in the range of US$ 1,91 to US$ 6,28 during the past year
What is the PE ratio of Vivos Therapeutics?
The price to earnings ratio of Vivos Therapeutics is -1,11
What is the cash to sales ratio of Vivos Therapeutics?
The cash to sales ratio of Vivos Therapeutics is 1,09
What is the reporting currency for Vivos Therapeutics?
Vivos Therapeutics reports financial results in USD
What is the latest annual turnover for Vivos Therapeutics?
The latest annual turnover of Vivos Therapeutics is USD 13,8M
What is the latest annual profit for Vivos Therapeutics?
The latest annual profit of Vivos Therapeutics is USD -13,58M
What is the registered address of Vivos Therapeutics?
The registered address for Vivos Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Vivos Therapeutics website address?
The website address for Vivos Therapeutics is vivos.com
Which industry sector does Vivos Therapeutics operate in?
Vivos Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PRTGPortage Biotech Inc
US$ 9,60
(103,82%)
29,92M
LXRXLexicon Pharmaceuticals Inc
US$ 0,5741
(65,16%)
405,3M
DBVTDBV Technologies SA
US$ 6,12
(56,52%)
21,8M
MYSZMy Size Inc
US$ 1,79
(42,06%)
11,89M
LXEHLixiang Education Holding Company Ltd
US$ 17,70
(32,78%)
217,53k
STSSSharps Technology Inc
US$ 0,0421
(-72,43%)
214,43M
MISTMilestone Pharmaceuticals Inc
US$ 0,88
(-60,89%)
33,47M
XTIAXTI Aerospace Inc
US$ 1,23
(-50,00%)
1,82M
LGMKLogicMark Inc
US$ 0,0258
(-49,41%)
161,36M
ICONIcon Energy Corporation
US$ 0,0516
(-48,40%)
27,6M
LXRXLexicon Pharmaceuticals Inc
US$ 0,5741
(65,16%)
405,29M
DMNDamon Inc
US$ 0,0346
(-22,42%)
314,35M
NVDANVIDIA Corporation
US$ 109,67
(-1,58%)
229,88M
STSSSharps Technology Inc
US$ 0,0421
(-72,43%)
214,43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,845
(-7,30%)
200,21M

VVOS Finanzen

Finanzen
Rendering Error
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock